228 related articles for article (PubMed ID: 19126649)
1. Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells.
Abedin SA; Thorne JL; Battaglia S; Maguire O; Hornung LB; Doherty AP; Mills IG; Campbell MJ
Carcinogenesis; 2009 Mar; 30(3):449-56. PubMed ID: 19126649
[TBL] [Abstract][Full Text] [Related]
2. Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion.
Battaglia S; Maguire O; Thorne JL; Hornung LB; Doig CL; Liu S; Sucheston LE; Bianchi A; Khanim FL; Gommersall LM; Coulter HS; Rakha S; Giddings I; O'Neill LP; Cooper CS; McCabe CJ; Bunce CM; Campbell MJ
Carcinogenesis; 2010 Sep; 31(9):1650-60. PubMed ID: 20466759
[TBL] [Abstract][Full Text] [Related]
3. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
Banwell CM; MacCartney DP; Guy M; Miles AE; Uskokovic MR; Mansi J; Stewart PM; O'Neill LP; Turner BM; Colston KW; Campbell MJ
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2004-13. PubMed ID: 16609009
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.
Doig CL; Singh PK; Dhiman VK; Thorne JL; Battaglia S; Sobolewski M; Maguire O; O'Neill LP; Turner BM; McCabe CJ; Smiraglia DJ; Campbell MJ
Carcinogenesis; 2013 Feb; 34(2):248-56. PubMed ID: 23087083
[TBL] [Abstract][Full Text] [Related]
5. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3.
Malinen M; Saramäki A; Ropponen A; Degenhardt T; Väisänen S; Carlberg C
Nucleic Acids Res; 2008 Jan; 36(1):121-32. PubMed ID: 17999998
[TBL] [Abstract][Full Text] [Related]
6. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ
Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237
[TBL] [Abstract][Full Text] [Related]
7. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
[TBL] [Abstract][Full Text] [Related]
8. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.
Yu C; Markan K; Temple KA; Deplewski D; Brady MJ; Cohen RN
J Biol Chem; 2005 Apr; 280(14):13600-5. PubMed ID: 15691842
[TBL] [Abstract][Full Text] [Related]
9. Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1592-604. PubMed ID: 17715259
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic corruption of VDR signalling in malignancy.
Abedin SA; Banwell CM; Colston KW; Carlberg C; Campbell MJ
Anticancer Res; 2006; 26(4A):2557-66. PubMed ID: 16886664
[TBL] [Abstract][Full Text] [Related]
11. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.
Chang TH; Szabo E
Clin Cancer Res; 2002 Apr; 8(4):1206-12. PubMed ID: 11948134
[TBL] [Abstract][Full Text] [Related]
12. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
[TBL] [Abstract][Full Text] [Related]
14. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
15. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
Tagami T; Lutz WH; Kumar R; Jameson JL
Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
[TBL] [Abstract][Full Text] [Related]
16. A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant.
Kim DW; Park JW; Willingham MC; Cheng SY
Hum Mol Genet; 2014 May; 23(10):2651-64. PubMed ID: 24381310
[TBL] [Abstract][Full Text] [Related]
17. Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein.
Lempiäinen H; Molnár F; Macias Gonzalez M; Peräkylä M; Carlberg C
Mol Endocrinol; 2005 Sep; 19(9):2258-72. PubMed ID: 15905360
[TBL] [Abstract][Full Text] [Related]
18. Absence of vitamin D receptor (VDR)-mediated PPARγ suppression causes alopecia in VDR-null mice.
Saini V; Zhao H; Petit ET; Gori F; Demay MB
FASEB J; 2017 Mar; 31(3):1059-1066. PubMed ID: 27932380
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.
Lim HJ; Moon I; Han K
Endocrinology; 2004 Jun; 145(6):2886-95. PubMed ID: 15001550
[TBL] [Abstract][Full Text] [Related]
20. Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature.
Oppi S; Nusser-Stein S; Blyszczuk P; Wang X; Jomard A; Marzolla V; Yang K; Velagapudi S; Ward LJ; Yuan XM; Geiger MA; Guillaumon AT; Othman A; Hornemann T; Rancic Z; Ryu D; Oosterveer MH; Osto E; Lüscher TF; Stein S
Eur Heart J; 2020 Mar; 41(9):995-1005. PubMed ID: 31529020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
